Sunday / January 29. 2023
menu-logo menu-logo
brand-logo
Subscribe
Subscribe
Sunday / January 29. 2023
  • Read
    • Daily News
      • Financial
      • Insights
      • U.S.
      • International
    • Digital Issue
    • Cover Stories
    • Feature Articles
    • Company Spotlights
    • Exclusive Interviews
    • Executive Announcements
    • Forward Thinking
    • For You | For Your Field
    • Working Smart
    • New Perspectives
    • From the Publisher
  • Listen & Watch
    • Direct Approach
    • Iconic Insights
    • The DSN Podcast
  • Attend
    • Direct Selling University
    • Global Celebration
  • Achieve
    • Global 100 List
    • CCR Program
    • Best Places to Work
    • Bravo Awards
    • Legends
  • Research
    • Digital Momentum Index
    • Stock Watch
    • Stock Ticker
    • Supplier Directory
    • Resources
  • Engage
    • Supporter Program
    • VIP Text Alerts
  • About
    • About DSN
    • Subscribe
    • Advertise
    • Store
    • Connect
  • Search
Subscribe

USANA Reports Record Third Quarter Net Sales

BY DSN Staff | October 25, 2017 | read / Daily News / U.S.

Salt Lake City, Utah-based USANA Health Sciences, Inc. recently announced financial results for its fiscal third quarter ended Sept. 30, 2017.

For the third quarter of 2017, net sales were $261.8 million compared with $254.2 million in the prior-year period, or a 3.0 percent increase year over year. There was no meaningful year-over-year impact from changes in currency exchange rates on quarterly net sales. The company’s total number of active customers increased by 2.4 percent year over year to 563,000.

Net earnings for the third quarter were $23.8 million compared with $30.1 million during the prior-year period, a decrease of 21.0 percent. Higher SG&A expense and a higher effective tax rate reduced net earnings during the quarter as they have throughout 2017.

Earnings per diluted share for the third quarter were 97 cents compared with $1.20 in the prior year period, a decrease of 19.2 percent. The expense related to China and the company’s internal investigation into its China operations, which was disclosed in February 2017, negatively impacted the third quarter by approximately $1.9 million and earnings per diluted share by 5 cents. Weighted average diluted shares outstanding were 24.6 million for the third quarter of 2017, compared with 25.1 million in the prior-year period.

“The third quarter was significant for USANA, not only for delivering record quarterly sales, but because of the accomplishments and announcements we made during the quarter,” said CEO Kevin Guest. “In particular, we celebrated our 25th anniversary at our annual International Convention, where we introduced a new skincare line, Celavive®, and announced our plans to expand into four additional European countries. Celavive is formulated with our cell-signaling technology, InCelligence. Both the launch of Celavive and the rollout of our European expansion will take place throughout 2018. These announcements were well received by thousands of our Associates at our convention and demonstrate our commitment to improving the health of more individuals and families around the world.”

Regionally, net sales in the Asia-Pacific region increased by 4.7 percent to $199.3 million. Within Asia Pacific, net sales increased 5.5 percent in Greater China; increased 35.9 percent in North Asia; and decreased 3.8 percent in the Southeast Asia Pacific region. Sales growth in Greater China was primarily driven by 8.7 percent active customer growth in Mainland China, while sales growth in North Asia resulted from 39.1 percent active customer growth in South Korea. The total number of active customers in the Asia-Pacific region increased by 6.5 percent year-over-year.

Net sales in the Americas and Europe region decreased by 2.1 percent to $62.5 million, largely due to an 8.6 percent decrease in active customers.

“For the first time in nearly three years, the overall revenue impact from changes in currency exchange rates was neutral,” said Guest. “Our Asia-Pacific region continues to be the driver of our sales growth. While we continue to face a challenging trend in the Americas and Europe region, we will continue to offer short-term promotions leading up to the launch of Celavive and the opening of our new European markets next year.”

To see the full USANA Q3 2017 report, click here.

Posted in Daily News, U.S. and tagged Celavive, Direct Selling, DSN, effective tax rate, InCelligence, Kevin Guest, MLM, Multi-Level Marketing, Q3, sales, Salt Lake City, SG&A, shares, third quarter, USANA, USANA Health Sciences, USNA, Utah.
Related Articles
4Life Doubles Capacity with New Manufacturing Facility  January 19, 2023

4Life Doubles Capacity with New Manufacturing Facility 

Read more
Juice Plus+ Launches First TV Campaign   January 11, 2023

Juice Plus+ Launches First TV Campaign  

Read more
DSA Files Comments with US Department of Labor Regarding Independent Contractor Classification  December 15, 2022

DSA Files Comments with US Department of Labor Regarding Independent Contractor Classification 

Read more
brand-logo
The News You Need.
The Name You Trust.
Subscribe

Breaking global news, emerging trends and powerful stories conveniently curated to help direct selling executives stay informed, engaged and a step ahead.

  • Read
  • Listen & Watch
  • Attend
  • Achieve
  • Research
  • About
  • Connect
5717 Legacy Drive
Suite 250
Plano, Texas 75024
info@directsellingnews.com
Copyright 2023 Direct Selling News | All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Subscribe
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT